Pain Management and Surgical Devices Global Market – Forecast To 2025

Publishing Date : December, 2018
Report Code : HCMD0162
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Pain is a debilitating condition, which can arise from arthritis, cancer, fibromyalgia and trauma, which includes neuropathic pain and nociceptive pain. This report focuses on treating various pain conditions with electrotherapy devices, ablation devices and surgical procedures. Electrotherapy devices include Spinal cord stimulator, peripheral nerve stimulator, TENS and NMES devices. These devices use electricity to treat pain by blocking the pain signals passing from nerve to brain. Surgical procedures such as kyphoplasty and vertebroplasty are used to treat pain caused by degenerative disc disease, whereas ablation procedures such as Radiofrequency ablation and Cryoablation are used to treat chronic pain and cancer pain by damaging pain causing nerve tissue. Ablation procedure damages the nerve that causes the pain and stops the transmission of pain signals to the brain. Several other devices like spacers, screws and artificial discs are used to treat back pain and neck pain caused by degenerative disc disease.

According to IQ4I analysis, the pain management and surgical devices global market is expected to grow at a high single digit CAGR to reach $8,824.7 million by 2025. The pain management and surgical devices market is mainly segmented by products, treatment type, application, end-users and by geography.

Based on the products market is segmented into pain devices and pain surgery, among this pain devices accounted the largest revenue in 2018 and is expected to grow at a high single digit CAGR from 2018 to 2025. Pain devices segment is further classified into internal pain devices and external pain devices. Among the internal pain devices, spinal cord stimulator accounted the largest revenue in 2018 and is projected to grow at a high single digit CAGR from 2018 to 2025. Among the external pain devices, TENS is accounted for largest revenue in 2018 and is expected to grow at a low single digit CAGR from 2018 to 2025, other external pain device segment include ultrasound therapy, photobiomodulation therapy, microwave therapy, short wave therapy, vegus nerve stimulation therapy and is expected to grow at a low single digit CAGR from 2018 to 2025. Pain surgery segment is divided into Kyphoplasty and vertebroplasty, fixation devices, artificial disc replacement and ablation. Among this kyphoplasty and vertebroplasty accounted the largest revenue in 2018 and is expected to grow at a mid single digit CAGR from 2018 to 2025, artificial disc replacement is projected to grow at a high single digit CAGR from 2018 to 2025. In pain surgery, ablation segment is further classified into radiofrequency ablation and cryoablation. Among this, radiofrequency ablation accounted the largest revenue and is projected to grow at a mid single digit CAGR from 2018 to 2025. Cryoablation is expected to grow at a high single digit CAGR from 2018 to 2025.

Based on the treatment type, pain management and surgical devices are classified into Invasive and non invasive. Among this, invasive devices accounted the largest revenue in 2018 and expected to grow at a high single digit CAGR from 2018 to 2025.

The applications segment in the pain management and surgical device market is classified into neuropathic pain, cancer pain, failed back surgery syndrome (FBSS), musculoskeletal disorder (MSD) and other pain, Among these applications, MSD holds the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025, due to increase in incidence of musculoskeletal disorders.

Based on end-users, pain management and surgical devices market is segmented into hospitals, ambulatory surgical centers, pain management centers and others. In this segment, hospitals held the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025.

Pain management and surgical devices geographic market is segmented into four major regions namely North America, Europe, Asia Pacific and Rest of World (ROW). North American region commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR. However, Asia-Pacific is expected to grow at high single digit CAGR from 2018 to 2025.

Major players in pain management devices and surgical devices are Abbot Laboratories (U.S.), Boston Scientific (U.S.), Medtronic Inc. (Ireland), Avanos Medical Inc. (Halyard health Inc.) (U.S.), Nevrocorp (U.S.), Nuvectra corporation (U.S.), Stryker Corporation (U.S.), Johnson and Johnson (DePuy synthes), (U.S.), Merit medicals (U.S.), DJO Finance Ltd. (Chattanooga) (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • France
  • U.K.
  • Rest of Europe
  • Asia-Pacific 
  • Japan
  • China
  • India
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East and Others
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     RISE IN CHRONIC DISEASES AND PAIN DISORDERS
        • 3.3.1.2     ADVERSE EFFECTS OF PAIN MEDICINES AND STRINGENT REGULATIONS TO LIMITS OPIOIDS MEDICINE
        • 3.3.1.3     INCREASE IN A GERIATRIC POPULATION WITH CHRONIC PAIN
        • 3.3.1.4     TECHNOLOGICAL ADVANCEMENT
        • 3.3.1.5     REIMBURSEMENT IN PAIN MANAGEMENT DEVICES
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     AVAILABILITY OF ALTERNATIVE THERAPIES
        • 3.3.2.2     CONTRAINDICATIONS OF PAIN MANAGEMENT DEVICES
        • 3.3.2.3     HIGH COST OF PAIN MANAGEMENT DEVICES
        • 3.3.2.4     STRINGENT REGULATIONS FOR THE APPROVALS OF PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     JAPAN
      • 3.4.6     CHINA
      • 3.4.7     INDIA
    • 3.5     PATENT TRENDS
      • 3.5.1     INTRODUCTION
      • 3.5.2     PAIN MANAGEMENT AND SURGICAL DEVICES PATENT TREND
    • 3.6     TECHNOLOGICAL ADVANCEMENTS
      • 3.6.1     INTRODUCTION
      • 3.6.2     NANO-ELECTRODES AND WIRELESS TECHNOLOGY FOR NEUROMODULATION
      • 3.6.3     POINT OF CARE ULTRASOUND (POCUS) NEUROMODULATION
      • 3.6.4     MINIATURIZATION OF PAIN MANAGEMENT DEVICES
      • 3.6.5     TECHNOLOGICAL CONVERGENCE OF PAIN MANAGEMENT DEVICES
    • 3.7     PORTER’S FIVE FORCE ANALYSIS
      • 3.7.1     THREAT OF NEW ENTRANTS
      • 3.7.2     THREAT OF SUBSTITUTES
      • 3.7.3     BARGAINING POWER OF SUPPLIERS
      • 3.7.4     BARGAINING POWER OF BUYERS
      • 3.7.5     COMPETITIVE RIVALRY
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.9.1     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.9.2     MARKET SHARE ANALYSIS OF SPINAL CORD STIMULATOR BY MAJOR PLAYERS
      • 3.9.3     MARKET SHARE ANALYSIS OF RADIOFREQUENCY ABLATION DEVICES BY MAJOR PLAYERS
      • 3.9.4     MARKET SHARE ANALYSIS OF KYPHOPLASTY AND VERTEBROPLASTY DEVICES BY MAJOR PLAYERS
    • 3.10     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET PENETRATION AND NUMBER OF UNIT SOLD
      • 3.10.1     PAIN MANAGEMENT AND SURGICAL DEVICES MARKET PENETRATION
    • 3.11     PAIN MANAGEMNENT AND SURGICAL DEVICES NUMBER OF UNITS BY REGION
      • 3.11.1     SPINAL CORD STIMULATOR NUMBER OF UNITS BY REGION (2017-2025) (NO’S)
      • 3.11.2     RADIOFREQUENCY ABLATIO DEVICES NUMBER OF UNITS BY REGION
      • 3.11.3     ARTIFICIAL DISC REPLACEMENT DEVICES NUMBER OF UNITS BY REGION
    • 3.12     PAIN MANAGEMENT AND SURGICAL DEVICES COMPANY COMPARISON TABLE BY PRODUCTS
      • 3.12.1     SPINAL CORD STIMULATOR DEVICES
      • 3.12.2     TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR (TENS)
      • 3.12.3     ABLATION DEVICES
      • 3.12.4     KYPHOPLASTY & VERTEBROPLASTY
      • 3.12.5     FIXATION DEVICES AND ARTIFICIAL DISC REPLACEMENT
      • 3.12.6     OTHER PAIN MANAGEMENT DEVICES
  • 4     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     PAIN DEVICES
      • 4.2.1     INTERNAL PAIN DEVICES
        • 4.2.1.1     SPINAL CORD STIMULATOR
        • 4.2.1.2     PERIPHERAL NERVE STIMULATOR
        • 4.2.1.3     OTHER INTERNAL PAIN DEVICES
      • 4.2.2     EXTERNAL PAIN DEVICES
        • 4.2.2.1     TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
        • 4.2.2.2     NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
        • 4.2.2.3     OTHER EXTERNAL PAIN DEVICES
          • 4.2.2.3.1     ULTRASOUND
          • 4.2.2.3.2      PHOTOBIOMODULATION THERAPY
          • 4.2.2.3.3      OTHER THERAPY
    • 4.3     PAIN SURGERY
      • 4.3.1     KYPHOPLASTY & VERTEBROPLASTY
      • 4.3.2     FIXATION DEVICES
      • 4.3.3     ARTIFICIAL DISC REPLACEMENT
      • 4.3.4     ABLATION
        • 4.3.4.1     RADIOFREQUENCY ABLATION
        • 4.3.4.2     CRYOABLATION
  • 5     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY TREATMENT TYPE
    • 5.1     INTRODUCTION
    • 5.2     INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES
    • 5.3     NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES
  • 6     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     NEUROPATHIC PAIN
    • 6.3     CANCER PAIN
    • 6.4     FAILED BACK SURGERY SYNDROME (FBSS)
    • 6.5     MUSCULOSKELETAL DISORDERS (MSD)
    • 6.6     OTHER PAIN
  • 7     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY END-USERS
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS
    • 7.3     AMBULATORY SURGERY CENTER
    • 7.4     PAIN MANAGEMENT CENTERS & OTHERS
  • 8     REGIONAL ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
      • 8.2.1     U.S.
      • 8.2.2     REST OF NORTH AMERICA
    • 8.3     EUROPE
      • 8.3.1     GERMANY
      • 8.3.2     FRANCE
      • 8.3.3     U.K.
      • 8.3.4     REST OF EUROPE
    • 8.4     APAC
      • 8.4.1     JAPAN
      • 8.4.2     CHINA
      • 8.4.3     INDIA
      • 8.4.4     REST OF APAC
    • 8.5     ROW
      • 8.5.1     BRAZIL
      • 8.5.2     REST OF LATAM
      • 8.5.3     MIDDLE EAST & OTHERS
  • 9     COMPETITIVE LANDSCAPE
    • 9.1     INTRODUCTION
    • 9.2     APPROVALS
    • 9.3     NEW PRODUCT LAUNCH
    • 9.4     MERGERS AND ACQUISITIONS
  • 10     MAJOR COMPANIES
    • 10.1     ABBOTT LABORATORIES
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     AVANOS MEDICAL, INC. (HALYARD HEALTH, INC.)
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     BOSTON SCIENTIFIC CORPOARTION
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     DJO GLOBAL
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     JOHNSON AND JOHNSON
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     MEDTRONIC, PLC
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     MERIT MEDICALS SYSTEM INC.
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     NEVROCORP
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     NUVECTRA
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     STRYKER CORPORATION
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 2     SPINAL CORD STIMULATORS NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
      • TABLE 3     RADIOFREQUENCY ABLATION DEVICES NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
      • TABLE 4     ARTIFICIAL DISC REPLACEMETN DEVICES NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
      • TABLE 5     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 6     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 7     PAIN DEVICES GLOBAL MARKET REVENUE, BY SITE, (2017-2025) ($MN)
      • TABLE 8     PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 9     INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 10     INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 11     SPINAL CORD STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 12     PERIPHERAL NERVE STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 13     OTHER INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 14     EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 15     EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 16     TENS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 17     NMES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 18     OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 19     OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 20     ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 21     PHOTOBIOMODULATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 22     OTHER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 23     PAIN SURGERY GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 24     PAIN SURGERY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 25     KYPHOPLASTY & VERTEBROPLASTY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 26     FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 27     ARTIFICIAL DISC REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 28     ABLATION GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 29     ABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 30     RADIOFREQUENCY ABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 31     CRYOABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 32     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
      • TABLE 33     INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 34     NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 35     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 36     NEUROPATHIC PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 37     CANCER PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 38     FAILED BACK SURGERY SYNDROME GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 39     MUSCULOSKELETAL DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 40     OTHER PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 41     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
      • TABLE 42     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 43     AMBULATORY SURGERY CENTER GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 44     PAIN MANAGEMENT CENTERS & OTHERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 45     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 46     NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 47     NORTH AMERICA PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
      • TABLE 48     NORTH AMERICA INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 49     NORTH AMERICA EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 50     NORTH AMERICA OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 51     NORTH AMERICA PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 52     NORTH ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 53     NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
      • TABLE 54     NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 55     NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
      • TABLE 56     NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 57     EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 58     EUROPE PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
      • TABLE 59     EUROPE INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 60     EUROPE EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 61     EUROPE OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 62     EUROPE PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 63     EUROPE ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 64     EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
      • TABLE 65     EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 66     EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
      • TABLE 67     EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 68     APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 69     APAC PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
      • TABLE 70     APAC INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 71     APAC EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 72     APAC OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 73     APAC PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 74     APAC ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 75     APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
      • TABLE 76     APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 77     APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
      • TABLE 78     APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 79     ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 80     ROW PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
      • TABLE 81     ROW INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 82     ROW EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 83     ROW OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 84     ROW PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 85     ROW ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 86     ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
      • TABLE 87     ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 88     ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
      • TABLE 89     ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 90     APPROVALS (2016-2018)
      • TABLE 91     NEW PRODUCT LAUNCHES (2016-2018)
      • TABLE 92     MERGERS AND ACQUISITIONS (2016-2018)
      • TABLE 93     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 94     ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 95     ABBOTT LABORATORIES: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
      • TABLE 96     ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 97     AVANOS MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 98     AVANOS MEDICAL, INC.: TOTAL REVENUE, BY REGION, (2016-2018) ($MN)
      • TABLE 99     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 100     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 101     BOSTON SCIENTIFIC CORPORATION:REVENUE BY MEDICAL SURGERY, (2016-2018) ($MN)
      • TABLE 102     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 103     DJO GLOBAL: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 104     DJO GLOBAL: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 105     DJO GLOBAL: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 106     JOHNSON AND JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 107     JOHNSON AND JOHNSON: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 108     JOHNSON AND JOHNSON: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
      • TABLE 109     JOHNSON AND JOHNSON: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
      • TABLE 110     JOHNSON AND JOHNSON: TOTAL REVENUE BY REGION, (2016-2018) ($MN)
      • TABLE 111     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 112     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 113     MEDTRONIC, PLC: RESTORATIVE THERAPIES TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
      • TABLE 114     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 115     MERIT MEDICAL SYSTEM INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 116     MERIT MEDICALS SYSTEMS INC.: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 117     MERIT MEDICAL SYSTEM INC.: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 118     NEVROCORP : TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 119     NEVROCORP: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 120     NUVECTRA CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 121     NUVECTRA CORPORATION : TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 122     NUVECTRA CORPORATION : TOTAL REVENUE, BY PRODUCT SEGMENTS, (2016-2018) ($MN)
      • TABLE 123     NUVECTRA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 124     STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 125     STRYKER CORPORATION: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 126     STRYKER CORPORATION: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
      • TABLE 127     STRYKER CORPORATION: TOTAL REVENUE BY REGION, (2016-2018) ($MN)

      LIST OF FIGURES

      • FIGURE 1     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET
      • FIGURE 3     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     PAIN MANAGEMENT AND SURGICAL DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2013–2018)
      • FIGURE 9     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
      • FIGURE 12     SPINAL CORD STIMULATOR GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
      • FIGURE 13     RADIOFREQUENCY ABLATION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
      • FIGURE 14     KYPHOPLASTY AND VERTEBROPLASTY DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
      • FIGURE 15     PAIN MANAGEMENT AND SURGICAL DEVICES MARKET PENETRATION IN GLOBAL PAIN MANAGEMENT MARKET, 2018 (%)
      • FIGURE 16     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2018 V/S 2025) (%)
      • FIGURE 17     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION (2018 V/S 2025) (%)
      • FIGURE 18     PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 19     PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 20     INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 21     INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 22     OTHER INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 23     EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 24     EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 25     OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 26     PAIN SURGERY GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2018 V/S 2025) (%)
      • FIGURE 27     PAIN SURGERY GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 28     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY TREATMENT TYPE (2018 V/S 2025) (%)
      • FIGURE 29     INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 30     NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 31     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY APPLICATION (2018 V/S 2025) (%)
      • FIGURE 32     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY END-USERS (2018 V/S 2025) (%)
      • FIGURE 33     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN), CAGR (%)
      • FIGURE 34     PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY GEOGRAPHY (2018) (%)
      • FIGURE 35     NORTH AMERICA INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 36     NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
      • FIGURE 37     NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES SHARE,
      • FIGURE 38     U.S. PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 39     U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 40     U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 41     REST OF NORTH AMERICA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 42     REST OF NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 43     REST OF NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 44     EUROPE INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 45     EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER
      • FIGURE 46     EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 47     GERMANY PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 48     GERMANY PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 49     GERMANY PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 50     FRANCE PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 51     FRANCE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 52     FRANCE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 53     U.K. PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 54     U.K. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 55     U.K. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 56     REST OF EUROPE PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 57     REST OF EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 58     REST OF EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 59     APAC INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 60     APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
      • FIGURE 61     APAC PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 62     JAPAN PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 63     JAPAN PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 64     JAPAN PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 65     CHINA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 66     CHINA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 67     CHINA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 68     INDIA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 69     INDIA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 70     INDIA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 71     REST OF APAC PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE
      • FIGURE 72     REST OF APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 73     REST OF APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 74     ROW INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
      • FIGURE 75     ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
      • FIGURE 76     ROW PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 77     BRAZIL PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 78     BRAZIL PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 79     BRAZIL PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 80     REST OF LATAM PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 81     REST OF LATAM PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 82     REST OF LATAM PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 83     MIDDLE EAST & OTHERS PMSD MARKET, BY PRODUCT, PAIN DEVICES, BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 84     MIDDLE EAST & OTHERS PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
      • FIGURE 85     MIDDLE EAST & OTHERS PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
      • FIGURE 86     KEY GROWTH STRATEGIES, (2016-2018)
      • FIGURE 87     SWOT: ABBOTT LABORATORIES
      • FIGURE 88     SWOT: AVANOS MEDICAL, INC.
      • FIGURE 89     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 90     SWOT: DJO GLOBAL
      • FIGURE 91     SWOT: JOHNSON AND JOHNSON
      • FIGURE 92     SWOT: MEDTRONIC, PLC
      • FIGURE 93     SWOT: MERIT MEDICALS SYSTEMS, INC.
      • FIGURE 94     SWOT: NEVROCORP
      • FIGURE 95     SWOT: NUVECTRA
      • FIGURE 96     SWOT: STRYKER CORPORATION

      LIST OF COMPANIES MENTTIONED IN THE REPORT

      • 1     ABBOTT LABORATORIES
      • 2     ACTIVELIFETECH PVT, LTD
      • 3     ACUKNEE LLC
      • 4     ADITUS MEDICAL GMBH
      • 5     AMERICANIMEX CORPORATION
      • 6     ATRICURE, INC.
      • 7     AVANOS MEDICALS
      • 8     B. BRAUN MELSUNGEN AG
      • 9     BEURER GMBH
      • 10     BIOELECTRONICS CORPORATION
      • 11     BIO-MEDICAL RESEARCH (BMR) LTD
      • 12     BIONESS
      • 13     BIOPHOTAS
      • 14     BMK GLOBAL MEDICAL COMPANY
      • 15     BOSTON SCIENTIFIC CORPORATION
      • 16     CEFALY TECHNOLOGY
      • 17     DJO GLOBAL LLC (CHATTANOOGA)
      • 18     ELECTROCORE MEDICAL LLC
      • 19     ELECTROMEDICAL PRODUCTS INTERNATIONAL, INC
      • 20     ENDONOVO THERAPEUTICS
      • 21     ENEURA, INC.
      • 22     ENRAF-NONIUS BV
      • 23     EPIMED INTERNATIONAL, INC
      • 24     EVOMED
      • 25      FYSIOMED NV
      • 26     GLOBUS MEDICAL, INC
      • 27     GUANGZHOU LONGEST SCIENCE & TECHNOLOGY CO., LTD.
      • 28     GUIDED THERAPY SYSTEMS
      • 29     GYMNAUNIPHY NV
      • 30     HANNOX INTENATIONAL CORPORATION
      • 31     IBRAMED
      • 32     ISKRA MEDICAL D.O.O
      • 33     I-TECH MEDICAL DIVISION
      • 34     ITO PHYSIOTHERAPY AND REHABILITATION
      • 35     JOHARI DIGITAL HEALTHCARE LTD,
      • 36     JOHNSON AND JOHNSON (DEPUY SYNTHES)
      • 37     K2M, INC.
      • 38     LANAFORM
      • 39     LED TECHNOLOGIES, INC.
      • 40     LIGHTSTIM MEDICAL DEVICE
      • 41     LUMINA GROUP, INC.
      • 42     MAINSTAY MEDICAL INTERNATIONAL PLC
      • 43     MEDISANA GMBH
      • 44     MEDIHIGHTEC
      • 45     MEDOVEX CORPORATION
      • 46     MEDTRONIC PLC
      • 47     MERIT MEDICALS
      • 48     METTLER ELECTRONICS CORPORATION
      • 49     MULTI RADIANCE MEDICALS
      • 50     MYOTRONICS
      • 51     MYOSCIENCE, INC.
      • 52     NEURIMPULSE
      • 53     NEUROMETRIX
      • 54     NEUROS MEDICALS, INC.
      • 55     NEVRO CORP
      • 56     NUVECTRA CORPORATION
      • 57     OG WELLNESS TECHNOLOGIES CO., LTD.
      • 58     OMRON CORPORATION
      • 59     PAIN MANAGEMENT DEVICES
      • 60     PLATIUMED
      • 61     PRODORTH
      • 62     REGENESIS BIOMEDICAL, INC.
      • 63     RICH-MAR, INC.
      • 64     RS MEDICAL, INC.
      • 65     SPR THERAPEUTICS
      • 66     STIMWAVE LLC
      • 67     STORZ MEDICALS AG
      • 68     STRYKER CORPORATION
      • 69     SUBLIMED
      • 70     THERAGEN LLC
      • 71     TUV NORD
      • 72     XAVANT
      • 73     ZEALMAX INNOVATIONS PVT. LTD.
      • 74     ZETROZ SYSTEMS, LLC.
      • 75     ZIMMER BIOMET
      • 76     ZIMMER MEDIZINSYSTEME GMBH
      • 77     ZYNEX MEDICAL